中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2014年
9期
1592-1596
,共5页
伍金华%谢志威%车小群%李秀娟%黎淑贞
伍金華%謝誌威%車小群%李秀娟%黎淑貞
오금화%사지위%차소군%리수연%려숙정
流产,习惯性%程序性细胞死亡分子1%Th1/Th2型细胞因子%淋巴细胞免疫治疗
流產,習慣性%程序性細胞死亡分子1%Th1/Th2型細胞因子%淋巴細胞免疫治療
유산,습관성%정서성세포사망분자1%Th1/Th2형세포인자%림파세포면역치료
Abortion,habitual%Programmed death-1%Th1/Th2 type cytokines%Lymphocyte immunotherapy
目的:探讨外周血程序性细胞死亡分子1(PD-1)及血清中Th1/Th2型细胞因子变化在原因不明复发性流产(URSA)发病中的作用。方法采用流式细胞术测定140例URSA患者接受淋巴细胞免疫治疗前后外周血PD-1水平;采用ELISA法测定患者治疗前后血清Th1(IL-2、IFN-γ)/Th2(IL-4、IL-10)型细胞因子水平,同时以102例正常已生育妇女作为对照组。结果(1)淋巴细胞免疫治疗前与对照组相比,PD-1和Th2型细胞因子(IL-4和IL-10)显著下降(P均<0.05)。(2)淋巴细胞免疫治疗后与治疗前相比,Th1型细胞因子(IL-2和IFN-γ)含量明显下调(P均<0.05)。(3)淋巴细胞免疫治疗后与对照组相比,PD-1、Th1/Th2型细胞因子水平无显著性差别(P均>0.05)。(4)URSA患者外周血PD-1含量和血清中Th2型细胞因子水平呈正相关(r=0.67,r=0.81,P均<0.05);与Th1型细胞因子呈负相关(r=-0.55,r=-0.73,P均<0.05)。(5)淋巴细胞免疫治疗后,妊娠成功的妇女PD-1表达水平显著高于妊娠失败者(P<0.05)。结论 PD-1可能通过下调Th1/Th2型细胞因子的水平抑制URSA的发生发展。
目的:探討外週血程序性細胞死亡分子1(PD-1)及血清中Th1/Th2型細胞因子變化在原因不明複髮性流產(URSA)髮病中的作用。方法採用流式細胞術測定140例URSA患者接受淋巴細胞免疫治療前後外週血PD-1水平;採用ELISA法測定患者治療前後血清Th1(IL-2、IFN-γ)/Th2(IL-4、IL-10)型細胞因子水平,同時以102例正常已生育婦女作為對照組。結果(1)淋巴細胞免疫治療前與對照組相比,PD-1和Th2型細胞因子(IL-4和IL-10)顯著下降(P均<0.05)。(2)淋巴細胞免疫治療後與治療前相比,Th1型細胞因子(IL-2和IFN-γ)含量明顯下調(P均<0.05)。(3)淋巴細胞免疫治療後與對照組相比,PD-1、Th1/Th2型細胞因子水平無顯著性差彆(P均>0.05)。(4)URSA患者外週血PD-1含量和血清中Th2型細胞因子水平呈正相關(r=0.67,r=0.81,P均<0.05);與Th1型細胞因子呈負相關(r=-0.55,r=-0.73,P均<0.05)。(5)淋巴細胞免疫治療後,妊娠成功的婦女PD-1錶達水平顯著高于妊娠失敗者(P<0.05)。結論 PD-1可能通過下調Th1/Th2型細胞因子的水平抑製URSA的髮生髮展。
목적:탐토외주혈정서성세포사망분자1(PD-1)급혈청중Th1/Th2형세포인자변화재원인불명복발성유산(URSA)발병중적작용。방법채용류식세포술측정140례URSA환자접수림파세포면역치료전후외주혈PD-1수평;채용ELISA법측정환자치료전후혈청Th1(IL-2、IFN-γ)/Th2(IL-4、IL-10)형세포인자수평,동시이102례정상이생육부녀작위대조조。결과(1)림파세포면역치료전여대조조상비,PD-1화Th2형세포인자(IL-4화IL-10)현저하강(P균<0.05)。(2)림파세포면역치료후여치료전상비,Th1형세포인자(IL-2화IFN-γ)함량명현하조(P균<0.05)。(3)림파세포면역치료후여대조조상비,PD-1、Th1/Th2형세포인자수평무현저성차별(P균>0.05)。(4)URSA환자외주혈PD-1함량화혈청중Th2형세포인자수평정정상관(r=0.67,r=0.81,P균<0.05);여Th1형세포인자정부상관(r=-0.55,r=-0.73,P균<0.05)。(5)림파세포면역치료후,임신성공적부녀PD-1표체수평현저고우임신실패자(P<0.05)。결론 PD-1가능통과하조Th1/Th2형세포인자적수평억제URSA적발생발전。
Objective To study the effect of programmed cell death-1 (PD-1) in peripheral blood and T helper-1 type(Th1)/T helper-2 type(Th2) cytokine in serum in patients with unexplained recurrent spontaneous abortion(URSA). Methods Flow cytometry was used to measure the PD-1 of 140 unexplained recurrent spontaneous abortion women before and after lymphocyte immunotherapy;enzyme linked immunosorbant assay(ELISA) was used to measure Th1/Th2 type cytokines of the patients before and after lymphocyte immunotherapy, and control as 102 normal fertile women. Results (1) PD-1 and Th2 type cytokine levels were significantly decreased before the lymphocyte immunotherapy(P<0.05). (2) Th1 type cytokine were significantly down-regulated after the lymphocyte immunotherapy(P<0.05). (3) Compared with control group, PD-1, Th1/Th2 cytokine levels were not significantly different after the lymphocyte immunotherapy(P>0.05). (4) The levels of PD-1 in peripheral blood and Th2-type cytokines in serum with URSA patients were positively correlated (r=0.67, r=0.81, P<0.05);and Th1-type cytokines were negatively correlated (r=-0.55, r=-0.73, P<0.05). (5)The percentage of PD-1 was significantly higher in successful pregnant women than those in pregnant loss after lymphocyte therapy. Conclusion PD-1 may suppress the development of URSA by down-regulating the level of Th1/Th2 cytokines.